Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00006496 · ClinicalTrials.gov registry record
Molecular Epidemiology of Acute Respiratory Distress Syndrome (ARDS)
A clinical trial of Acute Respiratory Distress Syndrome and Lung Diseases, sponsored by Massachusetts General Hospital.
- Active
- Registry status
- 4,000
- Enrollment target
- 1
- Study location
NCT00006496: Active study of Acute Respiratory Distress Syndrome and Lung Diseases, sponsored by Massachusetts General Hospital.
NCT00006496 is a study of Acute Respiratory Distress Syndrome and Lung Diseases that is active but no longer recruiting, run by Massachusetts General Hospital. The registered enrollment target is 4,000 participants, above the 238-participant average among 31 other Acute Respiratory Distress Syndrome trials with a reported enrollment target (1581% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00006496, a study of Acute Respiratory Distress Syndrome and Lung Diseases, is active but no longer recruiting, sponsored by Massachusetts General Hospital.
- ACTIVE NOT RECRUITING
- Registry status
- 4,000 participants
- Enrollment target
- 1
- Study location
Study Summary
To examine the possible relationship between genetic factors and the acute respiratory distress syndrome (ARDS).
Conditions Studied
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,000 participants |
| Start Date | 2000-02 |
| Est. Completion | 2026-12 |
What the registry record for NCT00006496 still lists
NCT00006496 is an observational study that tracks outcomes without assigning an intervention. Its 4,000 participants enrollment target places it among the larger protocols in the corpus, above the 238-participant average among 31 other Acute Respiratory Distress Syndrome trials with a reported enrollment target (1581% higher).
The record links to 2 conditions, with Acute Respiratory Distress Syndrome appearing as the primary indexed condition, and to 0 interventions.
NCT00006496 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT00006496 about?
NCT00006496 is a clinical study titled "Molecular Epidemiology of Acute Respiratory Distress Syndrome (ARDS)". To examine the possible relationship between genetic factors and the acute respiratory distress syndrome (ARDS).
What is the current status of trial NCT00006496?
This trial is currently active not recruiting. The enrollment target is 4,000 participants. The study started on 2000-02. Estimated completion is 2026-12.
What conditions does trial NCT00006496 study?
This clinical trial studies the following conditions: Acute Respiratory Distress Syndrome, Lung Diseases.
Who is sponsoring clinical trial NCT00006496?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00006496 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Respiratory Distress Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00006496's enrollment target sits among peer trials
4,000 1st of 31 higher than 31 of 31 other Acute Respiratory Distress Syndrome trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Acute Respiratory Distress Syndrome trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS (Master Record)
RECRUITING · Phase 2
-
The ARISE Study - Use of Vertical Positioning
RECRUITING · NA
-
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort C: Bevacizumab
RECRUITING · Phase 2
-
Extracellular Vesicle Treatment for Acute Respiratory Distress Syndrome (ARDS) (EXTINGUISH ARDS)
RECRUITING · Phase 3
-
The Effects of Music Therapy on Adult Patients Requiring Mechanical Ventilation in the ICU
RECRUITING · NA
-
Dead Space and Inhaled Nitric Oxide in Pediatric Acute Respiratory Distress Syndrome
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00227253 · 4,000 participants
Chromosome 18 Clinical Research Center
- NCT00811148 · 4,000 participants
Florida Center for Brain Tumor Research
- NCT00897117 · 4,000 participants
Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer
- NCT00899301 · 4,000 participants
Collecting and Storing Tissue Samples From Women With or Without Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia